Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

BMS names Giovanni Caforio COO

This article was originally published in Scrip

Executive Summary

Bristol-Myers Squibb has promoted Dr Giovanni Caforio to chief operating officer and a member of its board of directors, effective from 5 June 2014. He will continue to report to Lamberto Andreotti, chief executive officer of the company. Previously, Dr Caforio was US president and chief commercial officer at BMS from 2011 to 2014. He originally joined the New York-based drugmaker in in 2000 as vice-president and general manager, Italy.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

SC025521

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel